Expert_Opinion_on_Emerging_Drugs

<i>Expert Opinion on Emerging Drugs</i>

Expert Opinion on Emerging Drugs

Academic journal

Expert Opinion on Emerging Drugs is a quarterly peer-reviewed medical journal publishing structured reviews on drugs/drug classes emerging onto the market across all therapy areas. Each review includes an "expert opinion" section, in which authors are asked to provide their personal view on the current status and future direction of the research discussed. It was established as Emerging Drugs in 1996, changing to its current name in 2001. It is published by Taylor & Francis. In 2021 the journal stated that it had an impact factor of 3.912.[1]

Quick Facts Discipline, Language ...

References

  1. [1]
    From journal Web site


Stub icon 1 Stub icon 2

This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
Share this article:

This article uses material from the Wikipedia article Expert_Opinion_on_Emerging_Drugs, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.